Current Issue

Mid-November 2025

Signals Through the Noise

The 2025 ASH Annual Meeting connects rigorous science with clear communication in an era of fractured information.

Viewpoints

Editor’s Corner

From Science Fiction to Science Reality: What I’ve Learned About Getting the Most Out of the ASH Annual Meeting

Education

Guest Commentary

Nutrition Support Could Influence Outcomes in Caring for Patients With Hematologic Malignancies

Spotlight

ASH Annual Meeting Preview

Education Program Features Integrative, Cross-Disciplinary Approach
Crowd-Sourced Topics, Cutting-Edge Research Are Highlights of Scientific Program
Community-Based Hematologists Encouraged to Foster Clinical Trial Participation
Session to Cover Synergy of AI, Hematology
Education Session Tackles Important Questions Relevant to the Changing Face of CML
Experts Reflect on, Look Toward the Future of Fetal Hemoglobin Reactivation Therapies
Experts to Discuss Co-Managing Complex Hematologic Issues During Pregnancy, Delivery

News

PDUFA Pending

Ziftomenib Could Be Effective Option to Treat R/R NPM1-Mutated AML

In a Different Vein: News from the Blood Journals

Phase III POLARIX Study Compares Symptoms in Patients With DLBCL Treated With Pola-R-CHP or R-CHOP
Watch-and-Wait Approach May Allow Certain Patients With JMML to Avoid HCT

Literature Scan

Hematologic Toxicities Affect Efficacy Outcomes of BCMA CAR T-Cell Therapy in MM, Study Shows
Serial Serum Free Light Chain MeasurementEnhances Monitoring Response, Progression in Multiple Myeloma

Data Stream

Mid-November 2025 Data Stream

Online Only

Literature Scan

Delayed CAR-T Associated With Worse Outcomes in DLBCL, Study Finds